AAV2/5-RPGR

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
90	網膜色素変性症	1

90. 網膜色素変性症

臨床試験数 : 147 / 薬物数 : 176 - (DrugBank : 43) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 110

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03252847 (ClinicalTrials.gov)	July 14, 2017	1/8/2017	Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) - Retinitis Pigmentosa GTPase Regulator (RPGR) ...	An Open Label, Multi-centre, Phase I/II Dose Escalation Trial of a Recombinant Adeno-associated Viru ...	X-Linked Retinitis Pigmentosa	Genetic: AAV2/5-RPGR	MeiraGTx UK II Ltd	Syne Qua Non Limited;Bionical Emas	Completed	5 Years	N/A	Male	49	Phase 1/Phase 2	United States;United Kingdom

First Previous1Next Last